[Combined chemotherapy in esophageal carcinoma-the effect of PF (A) P therapy (peplomycin, 5-fluorouracil, (adriamycin), cisplatin)].
Toda
H
H
Second Dept. of Surgery, Osaka University Medical School.
Tsujinaka
T
T
Kido
Y
Y
Ogawa
M
M
Shiozaki
H
H
Miyamoto
T
T
Kambayashi
J
J
Murata
A
A
Kobayashi
K
K
Nishiyama
K
K
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017663:Peplomycin
D001761:Bleomycin; D017663:Peplomycin; D004317:Doxorubicin; D002945:Cisplatin